Dr. Georgia Parkin completed her Master of Science at the University of Zurich, Switzerland, and her PhD at the Florey Institute of Neuroscience and Mental Health, at the University of Melbourne, Australia. Her research focuses on the measurement and analysis of biomarkers in saliva, blood, and cerebrospinal fluid that are associated with psychiatric and neurodegenerative disorders. She has published in the fields of Huntington’s Disease, Schizophrenia, Bipolar Disorder, and Concussion research, with expertise in both the clinical recruitment and assessment of patients, and laboratory analysis of samples.